Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas.
Journal: Scientific reports
Published: August 20, 2020
Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways.
Journal: Cancer immunology research
Published: November 27, 2018
Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV- and HPV+ Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 26, 2018
Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.
Journal: Cell reports
Published: March 06, 2018
Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 02, 2018
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
Journal: Cell reports
Published: August 01, 2017
Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133+ Skin Cancer Stem Cells.
Journal: Molecular cancer therapeutics
Published: May 18, 2017
Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers.
Journal: Cancer research
Published: March 02, 2017
Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 29, 2016
TRAF3 signaling: Competitive binding and evolvability of adaptive viral molecular mimicry.
Journal: Biochimica et biophysica acta
Published: February 17, 2016
CCR 20th anniversary commentary: Preclinical study of proteasome inhibitor bortezomib in head and neck cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 04, 2015
Last Updated: 09/26/2026